Top Story

Hospitalizations longer, costlier for children with juvenile dermatomyositis

Hospitalizations longer, costlier for children with juvenile dermatomyositis
December 10, 2018
In the Journals

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
Researchers found that the most prevalent adverse effect linked to immune checkpoint inhibitors was inflammatory arthritis, and although most patients received long…

Recapping the ACR Review Course: What You May Have Missed This Year

November 8, 2018
I always look forward to the ACR yearly review course for an engaging way to get updates on various topics in the field of rheumatology. It’s also a way to…
Meeting News

Rheumatologists 'must' respond to checkpoint inhibitor problem

October 21, 2018
CHICAGO — Rheumatologists, as well as the rheumatology specialty as a whole, must become more aware of, and develop treatments and guidelines for, the problem of…
More Headlines »

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »
Meeting News

VIDEO: Significant improvements for skin disease activity seen in patients with dermatomyositis treated with anabasum

November 15, 2017
More »

Ace the Case: A 29-Year-Old Man With Swelling of His Upper and Lower Lips and Tongue

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 29-year-old man who presents to the…
More »